Cantor Fitzgerald lowered the firm’s price target on Cigna (CI) to $350 from $400 and keeps an Overweight rating on the shares. Cantor is confident that Cigna can correct their stop-loss pricing ...

Shares of The Cigna Group (NYSE:CI – Get Free Report) gapped down prior to trading on Thursday after the company announced weaker than expected quarterly earnings. The stock had previously closed at ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

The villains were injectable specialty drugs like Keytruda and inpatient surgical procedures for seriously ill patients.

Q4 2024 Earnings Call Transcript January 30, 2025 Cigna Corporation misses on earnings expectations. Reported EPS is $6.64 ...

Mizuho Securities analyst Ann Hynes has maintained their bullish stance on CI stock, giving a Buy rating yesterday.Invest with Confidence: ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

A handful of people turned out to comment on plans to convert a former motel property in West Brattleboro into a residential ...

CI's Q4 results reflect a decline in Individual and Family Plans customers. Management expects 2025 adjusted EPS at a minimum ...

Fresh off underperforming Wall Street’s expectations in the fourth quarter, Cigna said it would work to lower costs for its ...

Cigna has deleveraged substantially after acquiring Express Scripts in late 2018 when Cigna's debt rose to over $42 billion, or debt/capital of 51%. Management has made good progress on its ...

CEO David Cordani highlighted Cigna's full-year revenue growth of $247 billion, a 27% increase, alongside adjusted EPS of $27.33, which fell short of expectations. He reaffirmed the company's ...